LakePharma Symposium - 2019

LakePharma is pleased to organize its annual Symposium to bring together individuals and organizations in the biotech community to discuss the latest developments in gene and cell therapies.

The 2019 symposium will cover topics in cell and gene therapies. The conference is designed to benefit scientists currently working in the biopharmaceutical industry who want to improve their awareness of the latest advancements in next-generation therapeutics, as well as non-scientists who seek a better understanding of the processes, challenges, and opportunities in the industry.

In addition to formal presentations, the symposium will include special topic workshops, a poster session, and a happy hour for networking. 

Register for the symposium today >>

Date:

Thursday, October 10, 2019

Location:

South San Francisco Conference Center, 255 South Airport Boulevard, South San Francisco, CA 94080

Organizing Committee:

Hua Tu, Ph.D.                                  CEO, LakePharma, Inc.

Norman Garceau, Ph.D.                  VP, Technical Operations, LakePharma, Inc.

Brian Zabel, Ph.D.                           Senior Director, Discovery Immunology, LakePharma, Inc.

Speakers:

 

 

Alan Ashworth, Ph.D., FRS
President of Helen Diller Family Comprehensive Cancer Center at UCSF

Michael Boychyn, Ph.D.
Vice President of Process
Development at REGENXBIO Inc.

Dean Felsher, MD, Ph.D.
Director of Oncology Research, 
Director of Translational Research
and Applied Medicine at Stanford
University

Everett Meyer, MD, Ph.D.
Medical and Scientific Director,
Cellular Therapy Facility
at Stanford University

Madhusudan Peshwa, Ph.D.
Chief Technology Officer of Global Cell
Therapy at GE Healthcare

David Schaffer, Ph.D.
Co- Founder & CSO of 4D Molecular
Therapeutics,
Director of the Berkeley
Stem Cell Center at UC Berkeley

Hua Tu, Ph.D.
President and CEO of LakePharma

  

       Pam Contag Ph.D.
          CEO, Bioeclipse
 
 

Schedule:

8:30 am -  5:30 pm, Thursday October 10, 2019

 

Agenda:

Directed Evolution of Novel Adeno-Associated Viral Vectors for Clinical Gene Therapy, David Schaffer, Ph.D., 4D Molecular Therapeutics

 

A Platform for Identifying Strategies for Reversing Cancer and Restoring the Immune Response, Dean Felsher, MD, Ph.D., Stanford University

 

Synthetic Lethal Approaches to Cancer Therapy, Alan Ashworth, Ph.D. FRS, UCSF

 

Clinical and Pre-Clinical Approaches Using T Regulatory Cells to Prevent or Treat Graft-versus-Host Disease, Everett Meyer, MD, Ph.D., Stanford University

 

The Combination of Immune Cells and Oncolytic Virus Creates A Unique Multi-Mechanistic Biotherapy for Treatment of Refractory Solid Tumors, Pam Contag, Ph.D., Bioeclipse

 

Comparison of Baculovirus (BV)-Sf9 and HEK293 Expression Systems for the Production of Adeno-Associated Virus (AAV) Vectors, Michael Boychyn, Ph.D., REGENXBIO

 

Industrializing the Manufacture of Cell and Gene Therapies, Madhusudan Peshwa, Ph.D., GE Healthcare

 

From CRO to CRDMO, LakePharma's Technology Development in Meeting Next-Generation Therapeutics Needs, Hua Tu, Ph.D., LakePharma

 

 

Parallel Lunch Workshops:

Alt-R CRISPR Genome Editing: Innovation Driving Solutions for HDR, Specificity, and Off-Target Analysis
Integrated DNA Technologies, Inc. | View Abstract

 

Integrated Workflow Solutions for Development of Cellular Therapies
Thermo Fisher Scientific | View Abstract

 

Expanding SPR Throughput Orders of Magnitude to Accelerate Therapeutic Antibody Discovery
Carterra | View Abstract

 

Panel Discussion on Cell Therapy GMP Manufacturing
LakePharma  | View Abstract

Announcements:

Attendee registration opening is now open. Register >>

 

Now accepting exhibitor applications and poster submissions

 

Please contact symposium@lakepharma.com for more information.


Get directions to the conference center

  • Parking is available at the conference center and additional parking is permitted in the lots at the adjacent Holiday Inn.
  • CalTrain shuttle service to the Conference Center is provided from the South San Francisco CalTrain station every 30 minutes during commute hours (until 9:43 am)

    Sponsors:

   

 

Registration: